chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Flushing, Headache, Heart rate increased, Hypertension
Clinical narrative: High blood pressure; flushing; nightmares during day and night naps; splitting headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD. Concurrent medical conditions included Penicillin allergy and Drug allergy (Allergies to sulfar).    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue). At the time of the report, HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Heart rate increased: unknown (Inconclusive) Unknown.         Concomitant medication history not reported. Treatment information was unknown.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Nightmare
Clinical narrative: High blood pressure; flushing; nightmares during day and night naps; splitting headache; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COPD. Concurrent medical conditions included Penicillin allergy and Drug allergy (Allergies to sulfar).    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue). At the time of the report, HYPERTENSION (High blood pressure), FLUSHING (flushing), NIGHTMARE (nightmares during day and night naps), HEADACHE (splitting headache) and FATIGUE (Fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Heart rate increased: unknown (Inconclusive) Unknown.         Concomitant medication history not reported. Treatment information was unknown.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Nausea, Pyrexia
Clinical narrative: Nausea; headache; slight temperature; chills; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), HEADACHE (headache), PYREXIA (slight temperature) and CHILLS (chills) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced NAUSEA (Nausea), HEADACHE (headache), PYREXIA (slight temperature) and CHILLS (chills). On 03-Mar-2021, NAUSEA (Nausea), HEADACHE (headache), PYREXIA (slight temperature) and CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Dizziness; low grade fever; Extreme Fatigue after vaccination; Nausea; terrible headache; Injection site was extremely sore; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea) and HEADACHE (terrible headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020 and Pneumonia.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea), HEADACHE (terrible headache), VACCINATION SITE PAIN (Injection site was extremely sore) and MYALGIA (Body aches). At the time of the report, DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea), HEADACHE (terrible headache), VACCINATION SITE PAIN (Injection site was extremely sore) and MYALGIA (Body aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product information was reported.  No treatment information was reported.   On 20 March 2021, patient started feeling 80% better.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Dizziness; low grade fever; Extreme Fatigue after vaccination; Nausea; terrible headache; Injection site was extremely sore; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea) and HEADACHE (terrible headache) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in April 2020 and Pneumonia.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea), HEADACHE (terrible headache), VACCINATION SITE PAIN (Injection site was extremely sore) and MYALGIA (Body aches). At the time of the report, DIZZINESS (Dizziness), PYREXIA (low grade fever), FATIGUE (Extreme Fatigue after vaccination), NAUSEA (Nausea), HEADACHE (terrible headache), VACCINATION SITE PAIN (Injection site was extremely sore) and MYALGIA (Body aches) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant product information was reported.  No treatment information was reported.   On 20 March 2021, patient started feeling 80% better.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: She is 17 years old, date of birth 3july2003; where she got the shot looked like a massive mosquito bite/big red ring about 4.5 inches in diameter; area was itchy; area was swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (where she got the shot looked like a massive mosquito bite/big red ring about 4.5 inches in diameter), VACCINATION SITE PRURITUS (area was itchy), VACCINATION SITE SWELLING (area was swollen) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She is 17 years old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE ERYTHEMA (where she got the shot looked like a massive mosquito bite/big red ring about 4.5 inches in diameter), VACCINATION SITE PRURITUS (area was itchy) and VACCINATION SITE SWELLING (area was swollen). On 18-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She is 17 years old, date of birth 3july2003). On 18-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She is 17 years old) had resolved. On 30-Mar-2021, VACCINATION SITE SWELLING (area was swollen) had resolved. At the time of the report, VACCINATION SITE ERYTHEMA (where she got the shot looked like a massive mosquito bite/big red ring about 4.5 inches in diameter) had not resolved and VACCINATION SITE PRURITUS (area was itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-065676 (E2B Linked Report).; Sender's Comments:  MOD21-065676:crosslink
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Nausea, Somnolence
Clinical narrative: This spontaneous case reported by a nurse, describes the occurrence of general malaise, somnolence (slept the rest of the day) and nausea (nauseated) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced general malaise, somnolence (slept the rest of the day) and nausea (nauseated). At the time of the report, general malaise, somnolence (slept the rest of the day) and nausea (nauseated) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments or concomitant medications. Patient rested for the day and felt better.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Malaise, Movement disorder, Pain in extremity
Clinical narrative: sore arm; it started itching; hives; Malaise; tired; one part of her body then stopped, then another part of her body and then stopped; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise) and FATIGUE (tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure (High blood pressure.). Concomitant products included CELECOXIB (CELEBREX), CELECOXIB, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and MONTELUKAST for an unknown indication, MONTELUKAST SODIUM (SINGULAIR).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were high blood pressure medications. Treatment medications taken were Benadryl and applied lotion.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: sore arm; it started itching; hives; Malaise; tired; one part of her body then stopped, then another part of her body and then stopped; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise) and FATIGUE (tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Blood pressure (High blood pressure.). Concomitant products included CELECOXIB (CELEBREX), CELECOXIB, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) and MONTELUKAST for an unknown indication, MONTELUKAST SODIUM (SINGULAIR).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (it started itching), URTICARIA (hives), MALAISE (Malaise), FATIGUE (tired), MOVEMENT DISORDER (one part of her body then stopped, then another part of her body and then stopped) and HEADACHE (headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications taken were high blood pressure medications. Treatment medications taken were Benadryl and applied lotion.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site is in red; Injection site arm got swollen; Injection site arm got very hot; Itching on the injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site arm got very hot), VACCINATION SITE PRURITUS (Itching on the injection site arm), VACCINATION SITE ERYTHEMA (Injection site is in red) and VACCINATION SITE SWELLING (Injection site arm got swollen) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on the injection site arm). On 29-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site arm got very hot) and VACCINATION SITE SWELLING (Injection site arm got swollen). On 30-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (Injection site is in red). On 24-Mar-2021, VACCINATION SITE PRURITUS (Itching on the injection site arm) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site arm got very hot), VACCINATION SITE ERYTHEMA (Injection site is in red) and VACCINATION SITE SWELLING (Injection site arm got swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment medication was not provided.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Neck pain
Clinical narrative: pain in the back; pain in the nape; temperature; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain in the nape), BODY TEMPERATURE (temperature) and BACK PAIN (pain in the back) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced NECK PAIN (pain in the nape) and BODY TEMPERATURE (temperature). On an unknown date, the patient experienced BACK PAIN (pain in the back). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, NECK PAIN (pain in the nape), BODY TEMPERATURE (temperature) and BACK PAIN (pain in the back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Illness, Infection, Myalgia, Nausea
Clinical narrative: achy; sick after the first dose; nauseous; feverish, but did not have fever; sore arm; blood work and had infection going on; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever) and VACCINATION SITE PAIN (sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History.  The patient's past medical history included No adverse event. Concomitant products included SIMVASTATIN, ACETYLSALICYLIC ACID (ASPIRINA FORTE [ACETYLSALICYLIC ACID]), COLECALCIFEROL (VITAMIN D 3) and FISH OIL for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever), VACCINATION SITE PAIN (sore arm) and INFECTION (blood work and had infection going on). At the time of the report, MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever), VACCINATION SITE PAIN (sore arm) and INFECTION (blood work and had infection going on) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Electrocardiogram: abnormal Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: achy; sick after the first dose; nauseous; feverish, but did not have fever; sore arm; blood work and had infection going on; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever) and VACCINATION SITE PAIN (sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History.  The patient's past medical history included No adverse event. Concomitant products included SIMVASTATIN, ACETYLSALICYLIC ACID (ASPIRINA FORTE [ACETYLSALICYLIC ACID]), COLECALCIFEROL (VITAMIN D 3) and FISH OIL for an unknown indication.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever), VACCINATION SITE PAIN (sore arm) and INFECTION (blood work and had infection going on). At the time of the report, MYALGIA (achy), ILLNESS (sick after the first dose), NAUSEA (nauseous), PYREXIA (feverish, but did not have fever), VACCINATION SITE PAIN (sore arm) and INFECTION (blood work and had infection going on) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Mar-2021, Electrocardiogram: abnormal Abnormal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Pyrexia, Vomiting
Clinical narrative: More lethargic; Fever102.4F; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of LETHARGY (More lethargic), PYREXIA (Fever102.4F) and VOMITING (Vomiting) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PHENOBARBITAL (PHENOBARBITONE COX), ONDANSETRON (ZOFRAN MELT), CYPROHEPTADINE, FAMOTIDINE, PHENYTOIN SODIUM (DILANTIN D.A.), LEVOTHYROXINE, DESMOPRESSIN, CLONIDINE, Lorazepam prn, PARACETAMOL (TYLENOL), IBUPROFEN (IBUPROFEN) and Nasal spray PRN for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced LETHARGY (More lethargic), PYREXIA (Fever102.4F) and VOMITING (Vomiting). At the time of the report, LETHARGY (More lethargic), PYREXIA (Fever102.4F) and VOMITING (Vomiting) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Heart rate increased, Tachycardia
Clinical narrative: weakness; high heart rate; tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HEART RATE INCREASED (high heart rate) and TACHYCARDIA (tachycardia) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness), HEART RATE INCREASED (high heart rate) and TACHYCARDIA (tachycardia). At the time of the report, ASTHENIA (weakness), HEART RATE INCREASED (high heart rate) and TACHYCARDIA (tachycardia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster, Malaise
Clinical narrative: not feel well; shingles; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (not feel well) and HERPES ZOSTER (shingles) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included Chickenpox.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MALAISE (not feel well) and HERPES ZOSTER (shingles). At the time of the report, MALAISE (not feel well) and HERPES ZOSTER (shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: Large red area in his left upper arm that is about five inches long and two inches wid; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Large red area in his left upper arm that is about five inches long and two inches wid) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included PRAVASTATIN, FOLIC ACID, VITAMIN D [VITAMIN D NOS], B & FOLIC and PROBIOTIC 10 for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Large red area in his left upper arm that is about five inches long and two inches wid). At the time of the report, VACCINATION SITE ERYTHEMA (Large red area in his left upper arm that is about five inches long and two inches wid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other Med: Multivitamins and Inhaler
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache, Myalgia, Oropharyngeal pain
Clinical narrative: joint pain; sore throat; bad headache; chills; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive in December 2020.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches). On an unknown date, the patient experienced ARTHRALGIA (joint pain). At the time of the report, OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever), MYALGIA (body aches) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: joint pain; sore throat; bad headache; chills; fever; body aches; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 virus test positive in December 2020.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever) and MYALGIA (body aches). On an unknown date, the patient experienced ARTHRALGIA (joint pain). At the time of the report, OROPHARYNGEAL PAIN (sore throat), HEADACHE (bad headache), CHILLS (chills), PYREXIA (fever), MYALGIA (body aches) and ARTHRALGIA (joint pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood pressure increased, Burning sensation, Fatigue, Feeling hot
Clinical narrative: could feel heat in her arm and chest; tongue started tingling; couldn't sleep; could feel the heat from her elbow to her wrist; nervous; felt anxious; Blood Pressure spiked up; a burning feeling; arm was sore; very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist) and NERVOUSNESS (nervous) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0C17AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPAFENONE, MONTELUKAST SODIUM (SINGULAIR), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist), NERVOUSNESS (nervous), ANXIETY (felt anxious), BLOOD PRESSURE INCREASED (Blood Pressure spiked up), BURNING SENSATION (a burning feeling), VACCINATION SITE PAIN (arm was sore) and FATIGUE (very tired). At the time of the report, VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist), NERVOUSNESS (nervous), ANXIETY (felt anxious), BLOOD PRESSURE INCREASED (Blood Pressure spiked up), BURNING SENSATION (a burning feeling), VACCINATION SITE PAIN (arm was sore) and FATIGUE (very tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported to have taken Benadryl for heat sensation after vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up Included No new Information
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nervousness, Paraesthesia oral, Vaccination site pain, Vaccination site warmth
Clinical narrative: could feel heat in her arm and chest; tongue started tingling; couldn't sleep; could feel the heat from her elbow to her wrist; nervous; felt anxious; Blood Pressure spiked up; a burning feeling; arm was sore; very tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist) and NERVOUSNESS (nervous) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0C17AZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included PROPAFENONE, MONTELUKAST SODIUM (SINGULAIR), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMIN C [ASCORBIC ACID], COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]), LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist), NERVOUSNESS (nervous), ANXIETY (felt anxious), BLOOD PRESSURE INCREASED (Blood Pressure spiked up), BURNING SENSATION (a burning feeling), VACCINATION SITE PAIN (arm was sore) and FATIGUE (very tired). At the time of the report, VACCINATION SITE WARMTH (could feel heat in her arm and chest), PARAESTHESIA ORAL (tongue started tingling), INSOMNIA (couldn't sleep), FEELING HOT (could feel the heat from her elbow to her wrist), NERVOUSNESS (nervous), ANXIETY (felt anxious), BLOOD PRESSURE INCREASED (Blood Pressure spiked up), BURNING SENSATION (a burning feeling), VACCINATION SITE PAIN (arm was sore) and FATIGUE (very tired) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient reported to have taken Benadryl for heat sensation after vaccination.   Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up Included No new Information
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Sinusitis
Clinical narrative: sinus infection; Bad headache behind her right ear; fatigue; muscle pain; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain). At the time of the report, SINUSITIS (sinus infection), HEADACHE (Bad headache behind her right ear), FATIGUE (fatigue) and MYALGIA (muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.  "Follow-up received on 13 May 2021 included no new information.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Follow up received included reporters mail id.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: developed erythema from the injection site down to her elbow; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE ERYTHEMA (developed erythema from the injection site down to her elbow) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 30-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (developed erythema from the injection site down to her elbow). At the time of the report, VACCINATION SITE ERYTHEMA (developed erythema from the injection site down to her elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain
Clinical narrative: Body was hurting; Body ache; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Body was hurting), MYALGIA (Body ache) and FATIGUE (Fatigue) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A21A and 013A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Hypertension and Hypercholesterolaemia. Concomitant products included METFORMIN for Diabetes, FENOFIBRATE for Hypercholesteraemia, HYDROCHLOROTHIAZIDE for Hypertension.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced PAIN (Body was hurting), MYALGIA (Body ache) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 30-Mar-2021, MYALGIA (Body ache) had resolved. At the time of the report, PAIN (Body was hurting) and FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chills, Fatigue
Clinical narrative: chills; tired for a few days; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and FATIGUE (tired for a few days) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010A21A and 006B21A) for COVID-19 vaccination.     Concurrent medical conditions included White coat hypertension (Have high blood pressure).   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced CHILLS (chills) and FATIGUE (tired for a few days). At the time of the report, CHILLS (chills) and FATIGUE (tired for a few days) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal normal.         The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medication reported   An electrocardiogram was performed  Treatment using steroid tablet, Pepcid for stomach, a children's dose of diphenhydramine, and diphenhydramine12.5mg every 4-6 hours was reported  Application of cold cloth on arm was reported
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pain in extremity
Clinical narrative: Body aches; Sore arm; Fatigue; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical History.     On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills). The patient was treated with IBUPROFEN ongoing from 27-Mar-2021 at an unspecified dose and frequency. At the time of the report, PAIN (Body aches), PAIN IN EXTREMITY (Sore arm), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasal congestion, Pain in extremity, Pyrexia
Clinical narrative: low grade fever; coughing; congestion; Sore left arm; This spontaneous case was reported by a patient family member or friend and describes the occurrence of PYREXIA (low grade fever), COUGH (coughing), NASAL CONGESTION (congestion) and PAIN IN EXTREMITY (Sore left arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for an unknown indication.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included APIXABAN (ELIQUIS), SOTALOL HYDROCHLORIDE, ATORVASTATIN, LISINOPRIL, EMPAGLIFLOZIN (JARDIANCE), INSULIN LISPRO (HUMALOG), INSULIN GLARGINE (LANTUS), DULAGLUTIDE (TRULICITY), METFORMIN and LAMOTRIGINE for an unknown indication.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore left arm). On 27-Mar-2021, the patient experienced COUGH (coughing) and NASAL CONGESTION (congestion). On 29-Mar-2021, the patient experienced PYREXIA (low grade fever). On 22-Mar-2021, PAIN IN EXTREMITY (Sore left arm) had resolved. On 30-Mar-2021, PYREXIA (low grade fever) had resolved. At the time of the report, COUGH (coughing) and NASAL CONGESTION (congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter called to enquire if it was normal to experience these events. Treatment information was not provided.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness, Injection site pain
Clinical narrative: Flu like symptoms; Headache; pain at the injection site; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), INJECTION SITE PAIN (pain at the injection site) and FATIGUE (fatigue) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A22A and 001A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, ATORVASTATIN, ASA and LOSARTAN for an unknown indication.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), INJECTION SITE PAIN (pain at the injection site) and FATIGUE (fatigue). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HEADACHE (Headache), INJECTION SITE PAIN (pain at the injection site) and FATIGUE (fatigue) outcome was unknown. Not Provided          Concomitant medication include vitamins.  No treatment medications were provided.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jul-2021: NNI FU - No new information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: M
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included Allergy (pollen allergies). Previously administered products included for an unreported indication: SIMVASTATIN.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 27-Mar-2021, the patient experienced URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. At the time of the report, URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms) had not resolved. Unknown This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     The patient's past medical history included Allergy (pollen allergies) since an unknown date and Cholesterol since an unknown date. Concomitant products included SIMVASTATIN for Cholesterol.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 27-Mar-2021, the patient experienced URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) at an unspecified dose and frequency and CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. At the time of the report, URTICARIA (hives all over the body/ still breaking out in hives where the majority are located his back and now on his arms) had not resolved. Unknown
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia
Clinical narrative: A little fever; Feeling "bah"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling "bah") and PYREXIA (A little fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 29-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling "bah"). On an unknown date, the patient experienced PYREXIA (A little fever). At the time of the report, FEELING ABNORMAL (Feeling "bah") and PYREXIA (A little fever) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  No concomitant medications reported by investigator  No treatment medications provided by the reporter.    This case was linked to MOD21-065712 (E2B Linked Report).; Sender's Comments:  MOD21-065712:Cross- linked no
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Paraesthesia
Clinical narrative: weakness; tingling face; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness) and PARAESTHESIA (tingling face) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (weakness) and PARAESTHESIA (tingling face). At the time of the report, ASTHENIA (weakness) and PARAESTHESIA (tingling face) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient enquired whether she should take the second dose. Treatment information was not provided.  Concomitant medications were not reported.